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membrane preparation from human astrocytoma cells
John R. HEPLER and T. Kendall HARDEN*
Program in Neurobiology and Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill,
NC 27514, U.S.A.
The efficacy of muscarinic-receptor agonists for stimulation of inositol phosphate formation and Ca2+
mobilization in intact 1321N1 human astrocytoma cells is correlated with their capacity for formation of a
GTP-sensitive high-affinity binding complex in membranes from these cells [Evans, Hepler, Masters, Brown
& Harden (1985) Biochem. J. 232, 751-757]. These observations prompted the proposal that a guanine
nucleotide regulatory protein serves to couple muscarinic receptors to the phospholipase C involved in
phosphoinositide hydrolysis in 1321N1 cells. Inositol phosphate (InsP) formation was measured in a cell-free
preparation from 1321N1 cells to provide direct support for this idea. The formation of InsP3, InsP2
and InsP, was increased in a concentration-dependent manner (Ko.5 - 5 /iM) by guanosine 5'-[y-
thio]triphosphate (GTP[S]) in washed membranes prepared from myo-[3H]inositol-prelabelled 132IN1 cells.
Both GTP[S] and guanosine 5'-[Ify-imido]triphosphate (p[NH]ppG) stimulated InsP formation by 2-3-fold
over control; GTP, GDP and GMP were much less efficacious. Millimolar concentrations of NaF also
stimulated the formation of inositol phosphates in membrane preparations from 1321N1 cells. In the
presence of 10,1M-GTP[S], the muscarinic cholinergic-receptor agonist carbachol stimulated
(KO5 10 ,uM) the formation of InsP above that achieved with GTP[S] alone. The effect of carbachol was
completely blocked by atropine. The order of potency of nucleotides for stimulation of InsP formation in
the presence of 500 /M-carbachol was GTP[S] > p[NH]ppG > GTP = GDP. Pertussis toxin, at concentra-
tions that fully ADP-ribosylate and functionally inactivate Gi (the inhibitory guanine nucleotide regulatory
protein), had no effect on InsP formation in the presence of GTP[S] or GTP[S] plus carbachol. These data
are consistent with the idea that a guanine nucleotide regulatory protein that is not Gi is involved in
receptor-mediated stimulation of InsP formation in 1321N1 human astrocytoma cells.
INTRODUCTION
The mechanism whereby activation of hormone
receptors results in an increase in the conversion of
phosphatidylinositol bisphosphate into InsP3 has not
been defined. However, this process probably involves a
guanine nucleotide regulatory protein. GTP or its
analogues have been shown to promote exocytotic release
of substances from mast cells (Gomperts, 1983) and
platelets (Haslam & Davidson, 1984). Pertussis toxin,
which ADP-ribosylates and inactivates Gi, also has been
shown to modify the phosphoinositide response to
hormones in several cells of bone-marrow origin (Brandt
et al., 1985; Ohta et al., 1985). Finally, several
laboratories have demonstrated guanine nucleotide-
mediated stimulation of phosphoinositide hydrolysis in
cell-free preparations (Litosch et al., 1985, 1986;
Cockroft & Gomperts, 1985; Smith et al., 1985; Wallace
& Fain, 1985; Uhing et al., 1985; Gonzales & Crews,
1985).
Activation of muscarinic cholinergic receptors on
1321N1 human astrocytoma cells results in hydrolysis of
phosphoinositides (Masters et al., 1984), mobilization of
Ca2+ (Masters et al., 1984) and activation of a
Ca2+-calmodulin-regulated phosphodiesterase (Meeker
& Harden, 1982; Tanner et al., 1986). These receptors do
not interact with adenylate cyclase (Meeker & Harden,
1982; Hughes et al., 1984) or Gi (Hughes et al., 1984;
Evans et al., 1985a). Nonetheless, the muscarinic
receptors of 1321N1 cells apparently interact with a
guanine nucleotide regulatory protein, as evidenced by
marked effects of guanine nucleotides on the binding of
muscarinic-receptor agonists in washed membranes from
these cells (Evans et al., 1985a,b). Circumstantial
evidence of a role for this putative protein in coupling
muscarinic receptors to the phospholipase C involved in
phosphoinositide hydrolysis has been provided by the
demonstration that the capacity of agonists to form a
GTP-sensitive high-affinity binding complex in mem-
branes from these cells is correlated with their efficacy for
stimulation of inositol phosphate formation and Ca2+
mobilization (Evans et al., 1985b). We now provide
direct evidence for the involvement of a guanine
nucleotide regulatory protein by demonstrating that
carbachol-stimulated inositol phosphate formation in
membranes from 1321N1 cells is guanine nucleotide-
dependent. Furthermore, fluoride also is shown to
stimulate inositol phosphate formation in membrane
preparations from these cells. Consistent with previous
results with this cell line (Masters et al., 1985; Martin
Vol. 239
Abbreviations used: InsP., InsP2, InsP1, inositol tris-, bis- and mono-phosphate; GTP[S], guanosine 5'-[y-thioltriphosphate; p[NH]ppG,
guanosine 5'-[f8y-imido]triphosphate; Gi, the inhibitory guanine nucleotide regulatory protein.
* To whom reprint requests should be sent.
141
J. R. Hepler and T. K. Harden
et al., 1985; Nakahata et al., 1986), data are presented
that indicate that this putative guanine nucleotide
regulatory- protein is not Gi.
MATERIALS AND METHODS
1321NI human astrocytoma cells were cultured as
previously described (Meeker & Harden, 1982). Cells
were grown to a confluent monolayer in 140 mm-diam.
dishes and then labelled for 48 h with 5 1tCi of
myo-[3H]inositol/ml in inositol-free Dulbecco's minimal
essential medium containing 500 fetal-calf serum.
Approx. 15-30 assays were carried out per dish of
confluent cells (150-300 ,ug of protein/assay). To prepare
132 IN1 membranes, the labelling medium was removed
and replaced by cold hypo-osmotic lysis buffer (10 mm-
Hepes/2 mm EGTA, pH 7.0). Cells were incubated in
lysis buffer at 4 °C for 15-20 min, the lysis buffer was
removed by aspiration, the dishes were scraped with a
rubber policeman, and tissue was collected in conical
micro-centrifuge tubes. The lysates were resuspended in
a final volume of 1.5 ml of cold lysis buffer and pelleted
twice by centrifugation at 15000 g for 1 min in an
Eppendorf micro-centrifuge. The washed membrane
pellet was resuspended in lysis buffer for assay. Under
these conditions, no intact cells were observed in the
membrane preparation, as determined by Trypan Blue
exclusion under microscopic examination. Membranes
were routinely prepared fresh, warmed to 37 °C, and used
immediately.
Assays were initiated by the addition of 100l1 of
membranes from myo-[3H]inositol-prelabelled cells to
100 #1 of prewarmed (37 °C) assay buffer. Final
concentrations in the reaction mixture were 110mM-
KCl, 10 mM-NaCl, 1 mM-KH2PO4, 20 mM-Hepes,
4 mM-MgCl2, 1 mM-EGTA, 10 mM-LiCl, 3 mm-Na2ATP,
8 mM-phosphocreatine and 12 units ofcreatine kinase/ml
(pH 7.0). All drugs, including agonists, antagonists and
guanine nucleotides, were mixed fresh in assay buffer and
included in the assay mixture described above. The
assays were terminated by the addition of 1.Oml of
ice-cold 5% (v/v) trichloroacetic acid to each assay tube.
The precipitate was removed by centrifugation (4000 g)
and trichloroacetic acid was extracted from each sample
by washing with 3 x 2 ml of diethyl etner. Residual ether
was removed by aspiration and exposure to N2 gas.
[3H]Inositol phosphates in the aqueous sample were
determined essentially as described by Masters et al.
(1984). The sugar products were verified by h.p.l.c.
analysis (N. Nakahata & T. K. Harden, unpublished
work) as described by Irvine et al. (1985).
In general, results were qualitatively reproducible
across experiments. However, the total amounts of
inositol phosphates measured varied according to the
amount of membranes used per assay (150-300,ug of
protein) and the time and efficiency of labelling of the
membrane phosphoinositide pool. In addition, the
percentage increase in inositol phosphate formation
observed in the presence of agonist plus guanine
nucleotide and guanine nucleotide alone over that
observed with no additions (i.e. controls) varied
somewhat from experiment to experiment. The reasons
for this are as yet unclear.
Experiments with pertussis toxin were carried out after
incubating cells overnight with toxin. Toxin was
prepared as previously described (Hughes et al., 1984).
Assays to measure GTP-mediated inhibition of forskolin-
stimulated adenylate cyclase activity in cell-free prepara-
tions and pertussis-toxin-catalysed [32P]ADP ribosyl-
ation of 1 321N1 membranes were performed as described
previously (Hughes et al., 1984; Evans et al., 1985a).
myo-[3H]Inositol was supplied by New England
Nuclear or American Radiolabelled Chemicals. Carb-
achol and atropine were supplied by Sigma. Guanine
nucleotides were supplied by Boehringer-Mannheim;
AG1-X8 Dowex resin was obtained from Bio-Rad.
Statistical analysis of the data was performed by
Student's t test.
Table 1. Guanine nucleotide specificity for inositol phosphate formation in 1321N1 membranes
Membranes were prepared from 1321N1 cells prelabelled with myo-[3H]inositol as described in the Materials and methods
section. Membranes were incubated at 37 °C for 10 min in the absence or presence of the indicated concentration of guanine
nucleotide, in the absence or presence of 500 ,M-carbachol. The data are presented as means+ S.E.M. of total inositol phosphate
formation and as percentages of control values, where control refers to inositol phosphate formation in the absence of either
guanine nucleotide or carbachol. The data are representative of three experiments. * Increase in inositol phosphate formation
by guanine nucleotide significantly greater than control (P < 0.05) ** increase in inositol phosphate formation by hormone plus
guanine nucleotide significantly greater than increase by guanine nucleotide alone (P < 0.05).
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Fig. 1. Carbachol-stimulated inositol phosphate formation in
washed 1321N1 membranes
Membranes were prepared from 1 321N1 cells prelabelled
with myo-[3H]inositol as described in the Materials and
methods section. Incubations were for 10 min at 37 °C in
assay buffer containing the indicated concentrations of
carbachol in the absence of additional drug (0) or in the
presence of 10 ,#M-GTP[S] (M) or GTP[S]+10 /ZM-atropine
(A). The data are means of triplicate determinations and
are representative of results from three experiments.
RESULTS
Addition of 10 I,M-GTP[S] to a washed membrane
preparation from 1321N1 cells previously labelled with
[3H]inositol resulted in an increase in inositol phosphate
formation (Table 1; Fig 1). In the absence of GTP[S],
carbachol had no effect on inositol phosphate formation
at all concentrations tested (Fig. 1). In contrast, in the
presence of GTP[S], carbachol increased inositol phos-
phate formation in a concentration-dependent manner
(Fig. 1). The Ko 5 for carbachol (10 ,SM) was similar to
that previously observed in studies of carbachol-
stimulated inositol phosphate formation in intact
1321N1 cells (Masters et al., 1984). The effect of
carbachol was apparently through a muscarinic cholin-
ergic receptor, since, in the presence of a saturating
concentration of atropine, carbachol was without effect
(Fig. 1).
As illustrated in Fig. 2, GTP[S] alone or in
combination with 500 uM-carbachol stimulated the
formation of InsPl, InsP2 and InsP3. Accumulation of
InsP3 reached a maximum within 1 min [preliminary
studies using intact 1321N1 cells indicate that carbachol
stimulates the rapid formation of the two isomers of
InsP3, Ins(1,3,4)P3 and Ins(1,4,5)P3, as well as
Ins(1,3,4,5)P4; however, in washed membrane prepara-
tions from 1321N1 cells, initial work suggests that
carbachol selectively stimulates the formation of
Ins(l,4,5)P3], accumulation of InsP2 was linear for at
least 5 min, and, after a lag of approx. 1 min, InsPj
accumulation was linear for at least 5 min (results not
shown). The K0,5 of GTP[S] for stimulation of
accumulation ofinositol phosphates under each condition
was 3-10/,M. Although GTP[S] was the most potent
nucleotide studied, inositol phosphate formation also
was increased by p[NH]ppG. In some experiments GTP,
GDP and GMP marginally increased (by 10-20%)
inositol phosphate formation. Carbachol also increased
inositol phosphate formation in the presence of p[NH]-
ppG, GTP and GDP, but not in the presence of GMP
(Table 1). NaF is a well-known activator of guanine
nucleotide regulatory proteins (Gilman, 1984). As
illustrated in Fig. 3, NaF at millimolar concentrations
also stimulated inositol phosphate formation in 1321N1
membranes in amounts comparable with those stimulated
by a maximally effective concentration of GTP[S].
An important unresolved question concerning receptor-
mediated regulation of inositol phosphate formation
centres on the identity of the putative regulatory protein
that subserves a trans-membrane signalling function in
this system. Although experiments with several bone-
marrow-derived cells (Brandt et al., 1985; Ohta et al.,
1985) suggest that Gi or a similar pertussis-toxin
substrate is involved in regulation of phosphoinositide
hydrolysis, experiments with other mammalian tissues do
not support this conclusion (Masters et al., 1985;
Schlegel et al., 1985). Information accumulated to date
for 1321N1 cells would support the latter group of
studies, since pertussis toxin has no effect on muscarinic-
receptor-mediated activation of cyclic AMP phospho-
diesterase (Hughes et al., 1984; Nakahata et al., 1986),
mobilization of Ca2+ (Masters et al., 1985), or hydrolysis
of phosphoinositides (Masters et al., 1985; Nakahata
et al., 1986). The availability of a cell-free preparation in
which phosphoinositide hydrolysis can be measured
provides another approach for examining the possible
role of Gi or a similar pertussis-toxin substrate in Ca2+
signalling. As illustrated in Fig. 4, pertussis toxin
reversed in a concentration-dependent manner the
capacity ofGTP to inhibit forskolin-stimulated adenylate
cyclase activity (Fig. 4a). The same results were obtained
if p[NH]ppG, rather than GTP, was used as the
nucleotide for inhibition (results not shown). As
discussed previously by Seamon & Daly (1982) and
supported by work from other laboratories (Hildebrandt
et al., 1982; Kurose et al., 1983), these data are
consistent with a functional inactivation of Gi. The Ko.5
for action of toxin was 10-20 ng/ml; the effects of GTP
were completely reversed at 46-100 ng/ml. Under these
conditions pertussis-toxin-catalysed incorporation of
[32P]ADP-ribose into the oc-subunit of Gi was decreased
by over 95%O (Fig. 4b, and Evans et al., 1985a). As
illustrated in Fig. 4(b), incubation of 1321N1 cells in the
presence of concentrations of toxin that were 10-100
times higher than those necessary to ADP-ribosylate and
functionally inactivate Gi had no effect on inositol
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Fig. 2. InsP1, InsP2 and InsP3 formation in the presence of GTPISI and carbachol
132INI membranes were prepared as described in the Materials and methods section. Incubations were for 10 min at 37 °C
in assay buffer containing the indicated concentrations of GTP[S] in the absence (A) or presence (0) of carbachol (CARB;
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Fig. 3. NaF-stimulated inositol phosphate formation in washed
1321N1 membranes
Membranes were prepared from 1321N1 cells prelabelled
with myo-[3H]inositol as described in the Materials and
methods section. Incubations were for 10 min at 37 °C in
assay buffer containing no further additions (CONT),
100 /sM-GTP[S], 500 /M-carbachol (CARB)+GTP[S], or
various concentrations of NaF (M). The data are
means +S.E.M. of triplicate determinations and are repre-
sentative of results from two experiments.
GTP[S]. Also, inositol phosphate formation in the
presence of GTP[S] alone was not affected by toxin
(results not shown).
DISCUSSION
The present work indicates that guanine nucleotides
stimulate the formation of inositol phosphates in
membranes from 132INI cells. In the absence of added
guanine nucleotide, carbachol had no effect, whereas in
the presence of guanine nucleotide, carbachol stimulated
inositol phosphate formation over that achieved with
guanine nucleotide alone. In addition, fluoride, which is
an activator of known guanine nucleotide regulatory
proteins, stimulates inositol phosphate formation in
washed 1321N1 membranes. Thus these studies directly
support our previous proposal of a role for a guanine
nucleotide regulatory protein in the muscarinic-recep-
tor/phosphoinositide response of 1321N1 cells (Evans
et al., 1985a). Although the work does not identify this
putative G-protein, it does confirm with a cell-free
response system the conclusions made previously with
intact tissue (Masters et al., 1985; Nakahata et al., 1986)
or N-ethylmaleimide-pretreated 1321N1 membranes
(Martin et al., 1985) that Gi or a similar pertussis-toxin
substrate is not involved in cholinergic action in these
cells. The availability of such a cell-free system should aid
in the identification of this functionally important
trans-membrane coupling protein. It also should promote
comparisons ofmechanism between the type of response
typified by muscarinic receptors of 132INI cells and that
typified by the fMet-Leu-Phe receptor of bone-marrow-
derived cells (Brandt et al., 1985; Ohta et al., 1985), which
apparently regulates phosphoinositide hydrolysis
through a protein that is a substrate for pertussis toxin.
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Fig. 4. Differential effects of pertussis toxin (PT) on GTP-
mediated inhibition of forskolin-stimulated adenylate
cyclase activity and muscarinic-receptor-mediated stimu-
lation of inositol phosphate formation in 1321N1
membranes
(a) Cells were incubated overnight with the indicated
concentrations of pertussis toxin. Membranes were
prepared and adenylate cyclase assays carried out in the
presence of 100 /sM-forskolin (control) or 100 ,sM-forsko-
lin + 316 4uM-GTP. The results are plotted as the percentage
of forskolin-stimulated adenylate cyclase activity in the
absence of GTP, and are means of quadruplicate
determinations, representative of results from three
experiments. (b) Cells were labelled with myo-[3H]inositol
as well as being pretreated overnight with the indicated
concentrations of pertussis toxin. Membranes were
prepared and incubated in the absence (control; CONT)
or presence of 500 /tM-carbachol (CARB)+ 10 ,uM-GTP[S].
The data are means +S.E.M. of quadruplicate determina-
tions and are representative of two experiments. Inset:
plasma membranes were prepared from cells treated
overnight with either vehicle or 500 ng of pertussis
toxin/ml. The membranes were then incubated with
pertussis toxin and [32P]NAD+, solubilized with SDS and
Vol. 239
from bovine brain by Sternweis & Robishaw (1984) and
Neer et al. (1984), is a potential candidate for the
regulatory protein involved in regulation of phospho-
inositide hydrolysis. However, although G. has been
shown to interact with muscarinic receptors in a model
phospholipid vesicle system (Florio & Sternweis, 1985),
Go may not be ubiquitous, and to date we have been
unable to obtain evidence for its presence in 132IN 1 cells
(G. L. Waldo, M. W. Martin, A. R. Hughes, T. Evans,
J. K. Northup & T. K. Harden, unpublished work).
Furthermore, Go is a substrate for pertussis toxin.
Assuming that the toxin modifies Go in a manner similar
to Gi, involvement of Go in the phosphoinositide
response of 1321N1 cells would result in pertussis-toxin-
induced prevention of inositol phosphate formation in
these cells. This is clearly not the case (Fig. 4, and
Masters et al., 1985; Nakahata et al., 1986). The product
of the ras gene is a membrane-bound guanine nucleotide
binding protein that has been implicated in phospho-
inositide metabolism (Berridge & Irvine, 1984). However,
to date no compelling evidence, aside from circumstantial,
has appeared to assign a defined role for the ras protein
in this pathway. Evans et al. (1986) have purified a
heretofore undescribed guanine nucleotide binding
protein from human placenta. Perhaps this protein,
which is composed of a GTP-binding a-subunit of
approx. Mr 25 000, is involved in regulation of phospho-
inositide hydrolysis in 1321NI cells. Our prejudice is that
the putative guanine nucleotide regulatory protein that
we propose to couple muscarinic receptors to phospho-
lipase C in 132IN1 cells subserves the same function for
many other hormones in other tissues. Both histamine
(Nakahata et al., 1986) and bradykinin (J. R. Hepler &
T. K. Harden, unpublished work) which increase inositol
phosphate formation in intact 132IN1 cells, have been
shown to increase inositol phosphate formation in a
guanine nucleotide-dependent manner in membranes
from these cells (J. R. Hepler & T. K. Harden, unpub-
lished work). The availability of a cell-free preparation
for analysis of this hormone signalling system should be
of considerable value in identification of the coupling
protein that is of crucial importance in the action of
many hormones.
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